dried over Na2SO4 and evaporated. FC (silica gel, column 8 ¥ 3 cm,
eluted with CH2Cl2–acetone 98 : 2) afforded a colorless foam of 3b
(110 mg, 72%) (Found: C, 66.99; H, 6.65; N, 10.64%. C52H62N7O7P
requires C, 67.30; H, 6.73; N, 10.56%); TLC (silica gel, CH2Cl2–
acetone 9 : 1): Rf 0.87; dH(250 MHz; CDCl3; Me4Si) 1.10 (6 H,
m, (CH3)2CH), 1.16 (12 H, m, 4 ¥ CH3), 1.74 (6 H, m, 2 ¥ CH2,
H-5-triazole), 8.56 (1 H, s, H-4-coumarin), 10.68 (1 H, s, NH); m/z
(ESI-TOF) 597.18 (M + Na+. C27H26N8O7Na requires 597.19).
Copper(I)-catalyzed [3 + 2] cycloaddition of oligonucleotides 12 or
13 with 3-azido-7-hydroxycoumarin 15
To the single-stranded oligonucleotide (5 A260 units), a 1 : 1 CuSO4–
TBTA ligand complex (0.05 cm3 of a 20 mM stock solution in
t-BuOH–H2O 1 : 9), tris(carboxyethyl)phosphine (TCEP; 0.05 cm3
of a 20 mM stock solution in water), 3-azido-7-hydroxycoumarin
(15; 0.05 cm3 of a 20 mM stock solution in dioxane–H2O 1 : 1),
sodium bicarbonate (0.05 cm3 of a 20 mM aq. solution) and
0.035 cm3 DMSO were added, and the reaction proceeded at room
temperature for 12 h. The reaction mixture was concentrated in a
speed vac and dissolved in 1 cm3 bidistilled water and centrifuged
for 20 min at 12 000 rpm. The supernatant solution was collected
and further purified by reversed-phase HPLC in the trityl-off
modus to give the ‘click’ product (oligonucleotide 18 or 19). The
molecular masses of 18 and 19 were determined by MALDI-TOF
mass spectrometry (Table 7).
∫
CH2CN), 2.18 (1 H, m, 2¢-Ha), 2.20 (2 H, m, C C-CH2), 2.52
∫
∫
(4 H, m, 2¢-Hb, C CH2, CH(CH3)2), 2.67 (1 H, m, C CH), 3.63
(2 H, m, 5¢-H), 3.77–3.79 (8 H, m, 2 ¥ CH3, OCH2), 4.23 (1 H,
m, 4¢-H), 4.75 (1 H, m, 3¢-H), 6.41 (1 H, t, J 6.3, 1¢-H), 6.74–7.45
=
(13 H, 3 m, arom. H), 8.39 (1 H, s, N CH) and 11.70 (1 H, s, NH);
dP(101 MHz; CDCl3; H3PO4) 149.0.
6-Amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-1,5-dihydro-3-
(7-hydroxycoumarin-1¢,2¢,3¢-triazol-4¢-yl)pentylidyne-4H-
pyrrolo[2,3-d]pyrimidin-4-one (17)
To a solution of 1 (368 mg, 1 mmol) and 15 (291 mg, 1.43 mmol)
in water and ethyl alcohol (v/v = 1 : 1, 30 cm3), a freshly prepared
1 M solution of sodium ascorbate (0.2 cm3, 0.20 mmol) in water
and copper(II) sulfate pentahydrate 7.5% in water (0.17 cm3,
0.05 mmol) were added. The mixture was stirred vigorously
overnight in the dark at rt for 15 h. The solvent was evaporated,
and the remaining residue was loaded on a silica gel column
FC (silica gel, column 10 ¥ 4 cm, eluted with CH2Cl2–MeOH
80 : 20). From the main zone 17 was obtained as a yellow powder
(300 mg, 53%); TLC (silica gel, CH2Cl2–MeOH 9 : 1): Rf 0.30;
lmax (MeOH)/nm 243 (e/dm3 mol-1 cm-1 17 200), 347 (13 300);
dH(250 MHz; [d6]DMSO; Me4Si) 1.60 (2 H, t, J 7.2, CH2), 1.81
(2 H, t, J 7.4, CH2), 2.08 (1 H, m, 2¢-Ha), 2.30 (1 H, m, 2¢-Hb), 2.41
Acknowledgements
We thank Dr. V. R. Sirivolu for supplying us with compound
17 and Mr. P. Ding for Fig. 4d. We also thank Mr. D. Jiang for
measuring the NMR spectra, Dr. T. Koch from Roche Diagnostics
GmbH, Penzberg, Germany, for the measurement of the MALDI
spectra and Mr. N. Q. Tran for the oligonucleotide syntheses. We
appreciate critical reading by Mr. S. Pujari. Financial support
by the Roche Diagnostics GmbH and ChemBiotech, Muenster,
Germany, is gratefully acknowledged.
∫
(2 H, m, CH2), 2.76 (2 H, t, J 7.3 Hz, C C-CH2), 3.48 (1 H, m, 5¢-
H), 3.74 (1 H, m, 4¢-H), 4.27 (1 H, m, 3¢-H), 4.89 (1 H, m, 5¢-OH),
5.19 (1 H, m, 3¢-OH), 6.23 (1 H, t, J 6.0, 1¢-H), 6.30 (2 H, s, NH2),
6.85 (1 H, s, H-5-coumarin), 6.91 (1 H, m, H-6-coumarin), 7.70–
7.74 (1 H, d, J 8.6, H-8-coumarin), 8.33 (1 H, s, H-5-triazole), 8.55
(1 H, s, H-4-coumarin) and 10.39 (1 H, s, HN); m/z (ESI-TOF)
596.18 (M + Na+. C28H27N7O7Na requires 596.20).
References
1 H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem., Int. Ed.,
2001, 40, 2004–2021.
2 H. C. Kolb and K. B. Sharpless, Drug Discovery Today, 2003, 8, 1128–
1137.
3 N. J. Agard, J. A. Prescher and C. R. Bertozzi, J. Am. Chem. Soc., 2004,
126, 15046–15047.
6-Amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-1,5-dihydro-3-
(7-hydroxycoumarin-1¢,2¢,3¢-triazol-4¢-yl)pentylidyne-4H-
pyrazolo[3,4-d]pyrimidin-4-one (16)
4 J. M. Langenhan and J. S. Thorson, Curr. Org. Synth, 2005, 2, 59–81.
5 E. Delamarche, B. Michel, C. Gerber, D. Anselmetti, H.-J. Gu¨ntherodt,
H. Wolf and H. Ringsdorf, Langmuir, 1994, 10, 2869–2871.
6 M. J. Joralemon, R. K. O’Reilly, C. J. Hawker and K. L. Wooley, J. Am.
Chem. Soc., 2005, 127, 16892–16899.
To a solution of 2d (100 mg, 0.27 mmol) and 15 (55 mg, 0.27 mmol)
in water and ethyl alcohol (v/v = 1 : 1, 8 cm3), a freshly prepared
1 M solution of sodium ascorbate (0.054 cm3, 0.054 mmol) in
water and copper(II) sulfate pentahydrate 7.5% in water (0.045 cm3,
0.0135 mmol) were added. The mixture was stirred vigorously
in the dark at rt for 15 h. The solvent was evaporated, and the
residue was applied to FC (silica gel, column 10 ¥ 4 cm, eluted
with CH2Cl2–MeOH 80 : 20). Evaporation of the main zone gave
a yellow powder of 16 (140 mg, 90%). TLC (silica gel, CH2Cl2–
MeOH 8 : 2): Rf 0.53; lmax (MeOH)/nm 243 (e/dm3 mol-1 cm-1 46
900), 347 (25 500); dH(250 MHz; [d6]DMSO; Me4Si) 1.62 (2 H, t,
J 8.4, CH2), 1.82 (2 H, t, J 8.9, CH2), 2.14 (1 H, m, 2¢-Ha), 2.50
7 M. R. Whittaker, C. N. Urbani and M. J. Monteiro, J. Am. Chem. Soc.,
2006, 128, 11360–11361.
8 J. E. Moses and A. D. Moorhouse, Chem. Soc. Rev., 2007, 36, 1249–
1262.
9 D. D. D´ıaz, S. Punna, P. Holzer, A. K. McPherson, K. B. Sharpless,
V. V. Fokin and M. G. Finn, J. Polym. Sci. Part A: Polym. Chem., 2004,
42, 4392–4403.
10 M. Malkoch, K. Schleicher, E. Drockenmuller, C. J. Hawker, T. P.
Russell, P. Wu and V. V. Fokin, Macromolecules (Washington, DC,
U. S.), 2005, 38, 3663–3678.
11 (a) P. M. E. Gramlich, C. T. Wirges, A. Manetto and T. Carell, Angew.
Chem., Int. Ed., 2008, 47, 8350–8358, and references therein; (b) P. M. E.
Gramlich, S. Warncke, J. Gierlich and T. Carell, Angew. Chem., Int. Ed.,
2008, 47, 3442–3444; (c) J. Gierlich, G. A. Burley, P. M. E. Gramlich,
D. M. Hammond and T. Carell, Org. Lett., 2006, 8, 3639–3642.
12 (a) A. J. Dirks, S. S. van Berkel, N. S. Hatzakis, J. A. Opsteen, F. L.
van Delft, J. J. L. M. Cornelissen, A. E. Rowan, J. C. M. van Hest,
F. P. J. T. Rutjes and R. J. M. Nolte, Chem. Commun., 2005, 4172–4174;
(b) S. S. Gupta, J. Kuzelka, P. Singh, W. G. Lewis, M. Manchester and
M. G. Finn, Bioconjugate Chem., 2005, 16, 1572–1579; (c) A. Moulin,
L. Demange, J. Ryan, D. Mousseaux, P. Sanchez, G. Berge´, D. Gagne,
∫
(2 H, s, CH2), 2.64 (1 H, m, 2¢-Hb), 2.77 (2 H, t, J 8.4, C C-CH2),
3.35 (2 H, m, 5¢-H), 3.75 (1 H, m, 4¢-H), 4.26 (1 H, m, 3¢-H), 4.72
(1 H, m, 5¢-OH), 5.22 (1 H, m, 3¢-OH), 6.26 (1 H, t, J 7.9, 1¢-H),
6.74 (2 H, s, NH2), 6.84 (1 H, s, H-5-coumarin), 6.91 (1 H, m,
H-6-coumarin), 7.71 (1 H, d, J 10.2, H-8-coumarin), 8.34 (1 H, s,
1386 | Org. Biomol. Chem., 2009, 7, 1374–1387
This journal is
The Royal Society of Chemistry 2009
©